Navigation Links
Pacemakers Change Biology of the Heart
Date:3/21/2008

Study with dogs shows devices much more than a mechanical fix for ailing patients

FRIDAY, March 21 (HealthDay News) -- In dogs with damaged hearts, implanted pacemakers triggered fast improvements in tissue levels and the activity of a number of proteins crucial to heart health, says a Johns Hopkins study.

The researchers said their findings are believed to be the first detailed chemical analysis of the biological effects a pacemaker has on the heart. This new information could lead to improvements in the use of combined pacemaker/drug treatments for congestive heart failure patients.

"We are learning that pacemaker therapy does profoundly more than just mechanically correct how the heart beats; in fact, it produces major chemical changes that benefit the muscle," lead investigator Khalid Chakir, a postdoctoral cardiology research fellow at Hopkins, said in a prepared statement.

In this study, Chakir and colleagues induced "wobbly, discoordinated contraction" in the hearts of 22 dogs. In half the dogs, this asymmetric heart failure was allowed to take its natural course. The other dogs received a cardiac pacemaker.

Tissue analysis found major changes in the production or activity levels of 17 proteins known to be involved with heart cell stress, survival and death. These changes were especially notable in the dogs that didn't have their hearts "retuned" by a pacemaker.

In the dogs that did receive a pacemaker, the tissue levels and activity of these proteins were restored toward normal. The findings were published online in Circulation.

"Our results really help explain how pacemakers act much like a drug, actually changing the biology of the heart, and also explain why people can feel so much better after just two to six months with the device," study senior investigator Dr. David Kass, a cardiologist and professor at the Johns Hopkins University School of Medicine and its Heart Institute, said in a prepared statement.

Each year in the United States, more than a million people are diagnosed with congestive heart failure, in which the heart weakens and isn't able to pump enough blood to the rest of the body. About 25 percent of congestive heart failure patients suffer from non-uniform heart contraction, which requires implantation of a pacemaker to restore normal heartbeat, according to background information in a news release about the study.

Pacemakers can help extend people's lives for month or years or help them return to normal daily activities. It had been believed that pacemakers simply provided a mechanical solution for heartbeat malfunction.

"Now that we have found that resynchronization is doing more fundamental things to the heart muscle, we should be able to better combine these devices with drugs to maximize long-term survival and outcomes," Kass said.

More information

The U.S. Food and Drug Administration has more about cardiac pacemakers.



-- Robert Preidt



SOURCE: Johns Hopkins Medicine, news release, March 6, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. IPods Dont Interfere With Heart Pacemakers
2. ACP to develop quality improvement tools to support internal medicine practice changes
3. Make Your Mammogram a Positive Experience: Author Offers Guidelines and Tips to Change Womens Negative Attitudes Toward Mammograms
4. Harris Corporation Awarded Contract to Develop National Health Information Exchange Gateway for Sharing Patient Records
5. IPC The Hospitalist Company Announces Board of Director Member Changes
6. Survey: 35% of Baby Boomer Nurses Plan a Career Change in the Next One to Three Years
7. Barrs PLIVA Subsidiary to Terminate GDR Deposit Agreement and Delist From London Stock Exchange
8. How does P wave dispersion change in patients with Wilsons disease?
9. Balance in Old Age Tied to Brain Changes
10. Isolagen, Inc. Receives Notification Letter from American Stock Exchange
11. Molecules that changed the world
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Pacemakers Change Biology of the Heart
(Date:12/8/2016)... ... December 08, 2016 , ... Catalent ... for drugs, biologics and consumer health products, today announced that it had joined ... 2006 as a non-profit organization to unite pharmaceutical and healthcare companies that share ...
(Date:12/8/2016)... ... December 08, 2016 , ... STAT courier is pleased ... a convenient service for Texas, they are expanding their presence in Dallas. One of ... spree that will bring new jobs to the Dallas and Forth Worth market. STAT ...
(Date:12/8/2016)... ... 08, 2016 , ... Today’s patients are encouraged to be ... SIGVARIS has created a new line of anti-embolism stockings to help prevent a ... benefits of graduated compression when transitioning from recovery to early rehabilitation. , The ...
(Date:12/8/2016)... ... December 08, 2016 , ... Vida Health, the digital health ... led by Canvas Ventures . Other investors include Nokia Growth Partners (NGP) and ... to serve more consumers who are managing chronic conditions or simply want ...
(Date:12/8/2016)... ... December 08, 2016 , ... The ... from offices headquartered in Hamilton County, is embarking on a charity drive with ... in finding new homes for orphaned or neglected senior dogs in the Cincinnati ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , 8. Dezember 2016 Mederi Therapeutics Inc . hat die ... nicht-operative Behandlungsmethode für gastroösophageale Refluxerkrankung (GERD) – in China ... ... Live Stretta procedure performed ... Liu, Director of Endoscopy at Wuhan Union Hospital ...
(Date:12/8/2016)... 2016 Research and Markets has announced the ... offering. ... The global chromatography market to grow at a CAGR ... 2016-2020, has been prepared based on an in-depth market analysis with inputs ... prospects over the coming years. The report also includes a discussion of ...
(Date:12/8/2016)... ALBANY, New York , December 8, 2016 ... the global Diabetes Injection Pens Market is expected ... as compared to US$4.9 bn in 2015. Between the forecast ... to rise at a CAGR of 7.9%. The leading players ... Nordisk A/S, Eli Lilly and Company, AstraZaneca plc., Biocon Ltd., ...
Breaking Medicine Technology: